Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study

BACKGROUND: Hydroxychloroquine is one of several agents being evaluated in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to examine whether patients with rheumatological conditions receiving chronic hydroxychloroquine therapy are at less risk of de...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentry, Chris A, Humphrey, Mary Beth, Thind, Sharanjeet K, Hendrickson, Sage C, Kurdgelashvili, George, Williams, Riley J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505552/
https://www.ncbi.nlm.nih.gov/pubmed/32984847
http://dx.doi.org/10.1016/S2665-9913(20)30305-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505552/
https://www.ncbi.nlm.nih.gov/pubmed/32984847
http://dx.doi.org/10.1016/S2665-9913(20)30305-2

Ejemplares similares